A CD44-regulating Multimodal Therapeutic Strategy for MAFLD-Associated Pancreatic Cancer Liver Metastasis.
Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a novel risk factor for pancreatic cancer, particularly early liver metastasis. However, the underlying mechanisms and effective therapeutic strategies remain largely unclear. Here, based on clinical databases, patient tissue samples, and singl...